Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 6
2011 10
2012 9
2013 4
2014 4
2015 7
2016 6
2017 4
2018 3
2019 12
2020 4
2021 5
2022 4
2023 6
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators. Weitz JI, et al. N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18. N Engl J Med. 2017. PMID: 28316279 Free article. Clinical Trial.
Acanthocytosis in an alectinib-treated patient.
Legland Ép Dejean AM, Plantamura J, Arnoux I, Paleiron N, Loosveld M, Buono Ép Foucher B. Legland Ép Dejean AM, et al. Among authors: paleiron n. Br J Haematol. 2022 Apr;197(2):131. doi: 10.1111/bjh.18020. Epub 2022 Feb 7. Br J Haematol. 2022. PMID: 35128635 No abstract available.
Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial.
Valery S, Simon-Tillaux N, Devouassoux G, Bonniaud P, Beurnier A, Boudjemaa A, Chenivesse C, Bourdin A, Gauquelin L, Guillo S, Taillé C, Estellat C; RAMSES Study Group. Valery S, et al. J Allergy Clin Immunol. 2024 Oct;154(4):922-932. doi: 10.1016/j.jaci.2024.05.023. Epub 2024 Jun 6. J Allergy Clin Immunol. 2024. PMID: 38848878 Clinical Trial.
[The role of the pulmonologist in an armed conflict].
Paleiron N, Karkowski L, Bronstein AR, Amabile JC, Delarbre D, Mullot JU, Cazoulat A, Entine F, le Floch Brocquevieille H, Dorandeu F. Paleiron N, et al. Rev Mal Respir. 2023 Feb;40(2):156-168. doi: 10.1016/j.rmr.2023.01.002. Epub 2023 Jan 21. Rev Mal Respir. 2023. PMID: 36690507 Review. French.
[Asbestos in the National Navy: Employment-exposure matrix].
Maille A, Paleiron N, Grassin F, André M, Dewitte JD, Pougnet R. Maille A, et al. Among authors: paleiron n. Rev Pneumol Clin. 2018 Dec;74(6):436-443. doi: 10.1016/j.pneumo.2018.08.002. Epub 2018 Sep 27. Rev Pneumol Clin. 2018. PMID: 30269937 Review. French.
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
Rambaud G, Mai V, Motreff C, Sanchez O, Roy PM, Auffret Y, Le Mao R, Gagnadoux F, Paleiron N, Schmidt J, Pastre J, Nonent M, Tromeur C, Salaun PY, Mismetti P, Girard P, Lacut K, Lemarié CA, Meyer G, Leroyer C, Le Gal G, Bertoletti L, Couturaud F; “PEP” investigators. Rambaud G, et al. Among authors: paleiron n. Thromb Res. 2023 Nov;231:58-64. doi: 10.1016/j.thromres.2023.09.013. Epub 2023 Sep 28. Thromb Res. 2023. PMID: 37806116
[A pericardial effusion].
Vinsonneau U, Brondex A, Paleiron N, Castellant P, Cornily JC, Arles F, Quiniou G. Vinsonneau U, et al. Among authors: paleiron n. Rev Med Interne. 2010 Jun;31(6):451-2. doi: 10.1016/j.revmed.2009.02.013. Epub 2009 Apr 2. Rev Med Interne. 2010. PMID: 19344984 French. No abstract available.
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients.
Mottier D, Girard P, Couturaud F, Lacut K, Le Moigne E, Paleiron N, Guellec D, Sanchez O, Cogulet V, Laporte S, Marhic G, Mismetti P, Presles E, Robert-Ebadi H, Mahé I, Plaisance L, Reny JL, Darbellay Farhoumand P, Cuvelier C, Le Henaff C, Lambert Y, Danguy des Deserts M, Rousseau Legrand C, Boutreux S, Bleher Y, Decours R, Trinh-Duc A, Armengol G, Benhamou Y, Daumas A, Guyot SL, De Carvalho H, Lamia B, Righini M, Meyer G, Le Gal G. Mottier D, et al. Among authors: paleiron n. NEJM Evid. 2023 Aug;2(8):EVIDoa2200332. doi: 10.1056/EVIDoa2200332. Epub 2023 Jun 27. NEJM Evid. 2023. PMID: 38320142 Clinical Trial.
Targeted therapy for localized non-small-cell lung cancer: a review.
Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C. Paleiron N, et al. Onco Targets Ther. 2016 Jul 5;9:4099-104. doi: 10.2147/OTT.S104938. eCollection 2016. Onco Targets Ther. 2016. PMID: 27462164 Free PMC article. Review.
78 results